openPR Logo
Press release

DBD INVESTMENT BANK Announces Strategic Expansion with New West Coast and Salt Lake City Offices

05-28-2025 03:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

DBD INVESTMENT BANK Announces Strategic Expansion with New West

NEW YORK, NY - DBD INVESTMENT BANK [https://www.dbdinvestmentbank.com/], one of the fastest-growing independent investment banking firms specializing in mergers and acquisitions, capital raising, debt restructuring, and strategic advisory services, today announced its continued national expansion with the addition of key senior executives in Los Angeles and Salt Lake City.

Philip Alberstat [https://www.linkedin.com/in/philip-alberstat-97299912/] joins DBD INVESTMENT BANK as Head of West Coast Operations and TMT (Technology, Media, and Telecom) Practice Lead, based in Los Angeles. With extensive experience in media finance and technology investment banking, Alberstat will spearhead the firm's expansion throughout California and the broader West Coast region, while also leading DBD INVESTMENT BANK's growing TMT advisory practice nationwide.

"Expanding our footprint to the West Coast represents a pivotal milestone in DBD 's accelerated growth strategy," said Iliya Zogovic [https://www.linkedin.com/in/iliya-zogovic/], Founder and Chief Executive Officer of DBD INVESTMENT BANK. "The addition of Philip Alberstat, with his deep industry expertise and strong client relationships in the TMT sector, significantly enhances our ability to serve clients in this dynamic and rapidly evolving market."

Philip Alberstat expressed enthusiasm about his new role, stating, "I'm thrilled to join DBD at such an exciting time in the firm's growth trajectory. The West Coast, particularly Los Angeles, continues to be a hub for innovation across the technology, media, and telecom sectors. I look forward to leveraging my experience to help our clients navigate complex transactions and achieve their strategic objectives."

DBD INVESTMENT BANK also announced the opening of its new Salt Lake City office, appointing Maxwell Walters as Director to lead the firm's presence in Utah. This strategic expansion reinforces DBD INVESTMENT BANK's commitment to providing localized expertise with national reach.

With these additions, DBD INVESTMENT BANK now maintains offices in New York City (headquarters), White Plains, Los Angeles, and Salt Lake City, enabling the firm to better serve middle-market and growth companies across the United States. The firm's rapid expansion reflects its strong momentum in the investment banking sector and growing client demand for its services.

Zogovic added, "Our expansion into key markets across the United States is a direct response to increasing client demand for our specialized advisory services. By establishing a presence in strategic locations like Los Angeles and Salt Lake City, we're positioning DBD INVESTMENT BANK to capitalize on emerging opportunities while ensuring we maintain the personalized approach and industry expertise that have fueled our growth to date."

About DBD INVESTMENT BANK

DBD INVESTMENT BANK is a leading independent firm providing strategic and financial advice to middle-market companies, entrepreneurs, and investors. As one of the fastest-growing boutique investment banks, it specializes in mergers and acquisitions, capital raising, and strategic advisory services across Business Services, Consumer Products and Retail, Healthcare and Life Sciences, Industrial Manufacturing, Technology, Media, and Telecommunications (TMT), as well as Education and Construction services. Since its inception, DBD INVESTMENT BANK has executed numerous transactions spanning sell-side and buy-side M&A, capital raising, debt restructuring, and strategic consulting. Its growth stems from a relationship-focused approach, deep industry expertise, and commitment to exceptional client outcomes.

For more information about DBD INVESTMENT BANK, please visit: https://www.dbdinvestmentbank.com/

Note: This press release contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected.

Media Contact
Company Name: DBD INVESTMENT BANK
Contact Person: Caleb Harper
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dbd-investment-bank-announces-strategic-expansion-with-new-west-coast-and-salt-lake-city-offices]
Country: United States
Website: https://www.dbdinvestmentbank.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DBD INVESTMENT BANK Announces Strategic Expansion with New West Coast and Salt Lake City Offices here

News-ID: 4040779 • Views:

More Releases from ABNewswire

Idiopathic Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi
Idiopathic Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Idiopathic Pulmonary Fibrosis pipeline constitutes 80+ key companies continuously working towards developing 100+ Idiopathic Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Idiopathic Pulmonary Fibrosis Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/idiopathic-pulmonary-fibrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Idiopathic Pulmonary Fibrosis Market. The
Global Sound Reinforcement Market Set to Grow at 4.28% CAGR, Reaching USD 38.58 Billion by 2030 | Arizton
Global Sound Reinforcement Market Set to Grow at 4.28% CAGR, Reaching USD 38.58 …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030. The global sound reinforcement market [https://www.arizton.com/market-reports/sound-reinforcement-market-size-growth] is projected to expand from USD 30 billion in 2024 to USD 38.58 billion by 2030, growing at a steady 4.28% CAGR, according to Arizton. This growth is being driven by rising demand for high-quality audio solutions across live events and entertainment venues. Advances in audio technology have significantly enhanced
Gelt Raises $13M Series A to Expand AI-Powered Tax Solutions for Real Estate Investors
Gelt Raises $13M Series A to Expand AI-Powered Tax Solutions for Real Estate Inv …
Miami, FL - September 30, 2025 - Gelt [https://www.joingelt.com/], the first AI-native tax firm for investors and the Top 1% in the U.S., today announced it has raised $13 million in Series A [https://www.businesswire.com/news/home/20250930325477/en/Gelt-the-First-AI-Native-Tax-Firm-Raises-%2413M-in-Series-A-Funding-to-Transform-Tax-Strategy-Into-Year-Round-Wealth-Optimization], bringing its total funding to $21.2 million. Global investors, Zvi Limon of the Rimon Group, Vintage Investment Partners, and TLV Partners led the funding. As part of the launch, Yoram Tietz, former Managing Partner at EY
Applications of 5-50mm security camera lens
Applications of 5-50mm security camera lens
The application scenarios of 5-50 mm surveillance lenses are primarily categorized according to the variations in field of view resulting from changes in focal length. The specific applications are as follows: 1. Wide-angle range (5-12 mm) Panoramic monitoring for confined spaces A focal length of 5-8 mm (with a field of view of 60 degrees -90 degrees ) is suitable for enclosed small areas within 5 times 5 meters, such as elevator

All 5 Releases


More Releases for DBD

Disruptive Behavior Disorder (DBD) Treatment Market Set to Reach USD 25.4 Billio …
The disruptive behavior disorder (DBD) treatment market was valued at approximately USD 15.3 billion in 2023 and is anticipated to reach USD 25.4 billion by 2033, growing at a CAGR of 5.3% from 2024 to 2033. This growth reflects increasing recognition of the importance of early diagnosis and intervention in childhood behavioral disorders, as well as expanding access to comprehensive treatment solutions globally. Disruptive Behavior Disorders encompass several conditions including Oppositional
Disruptive Behavior Disorder (DBD) Medication Market Set to Witness Rising Deman …
Disruptive Behavior Disorder (DBD) Medication Market Overview The Disruptive Behavior Disorder (DBD) Medication Market is projected to grow from USD 1.3 Billion in 2025 to USD 2 Billion by 2032, at a CAGR of 6.2%. The latest report (2025-2032) on the Disruptive Behavior Disorder (DBD) Medication Market by Coherent Market Insights offers an in-depth analysis of evolving trends, key drivers, regulatory updates, and competitive intelligence. It provides data on market size, revenue,
Disruptive Behavior Disorders (DBD) Market Demands, Overview, Size, Trend, and K …
Disruptive Behavior Disorders (DBD) Market report helps understand whether the demand for the products in this industry will rise or get lower. Qualitative and transparent research studies are performed devotedly to offer you an excellent market research report for your niche. The report is accomplished with transparent research studies and is generated by the teamwork of experts in their own domain. Click Here For Free Sample + Related Graphs of the
Investigation announced for Long-Term Investors in Diebold Nixdorf, Incorporated …
An investigation on behalf of current long-term investors in shares of Diebold Nixdorf, Incorporated (NYSE: DBD) concerning potential breaches of fiduciary duties by certain directors and officers of Diebold Nixdorf, Incorporated was announced. Investors who are current long term investors in Diebold Nixdorf, Incorporated (NYSE: DBD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for
Disruptive Behavior Disorder Dbd Treatment Market :- Top Leading Players are Pfi …
This Disruptive Behavior Disorder Dbd Treatment market report highlights key market dynamics of Medical Devices industry and covers historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Attaining complete info about the trends and opportunities in the industry is fairly time consuming process which is eased with this report. Top players in the market, major collaborations, merger and acquisitions along with
(NYSE: DBD) Investor Alert: Deadline upcoming in Lawsuit against Diebold Nixdorf …
A deadline is coming up on September 3, 2019 in the lawsuit filed for certain investors of Diebold Nixdorf, Incorporated (NYSE: DBD) over alleged securities laws violations by Diebold Nixdorf, Incorporated. Investors who purchased shares of Diebold Nixdorf, Incorporated (NYSE: DBD) have certain options and there are strict and short deadlines running. Deadline: September 3, 2019. NYSE: DBD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -